U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07921797) titled 'Long-Term Performance of Kingstron X-LINK Compared With Commercial Bioprostheses' on Nov. 02.
Brief Summary: The goal of this prospective cohort study is to evaluate the long term clinical performance of the Kingstron X LINK bioprosthesis for aortic or mitral valve replacement, and verify whether its postoperative outcomes are non inferior to commercially available Medtronic Mosaic and Edwards Perimount Magna bioprostheses. It will also assess safety, hemodynamic performance and patient quality of life after valve implantation. The main questions it aims to answer are: Does the Kingstron X LINK bioprosthesis yield non inferior long t...